Gene expression mapScientists at the School of Medicine have developed a method to predict whether melanoma of the eye will spread to the liver, where it quickly turns deadly. They also believe the molecular screening test may one day help determine the prognosis of patients with some types of skin melanoma. The researchers found that a particular molecular signature — a pattern of activation of a group of genes in the tumor cells — accurately predicts risk for metastasis.
An approach proven to cure a rat model of type 1 or juvenile-onset diabetes also works in a rat model of type 2 or adult-onset diabetes, according to a new report from researchers at the School of Medicine.
An approach proven to cure a rat model of type 1 or juvenile-onset diabetes also works in a rat model of type 2 or adult-onset diabetes, according to a new report from researchers at the School of Medicine.
A long-term study of the elderly has revealed that their average rate of weight loss doubles in the year before symptoms of Alzheimer’s-type dementia first become detectable. The finding may be useful to researchers seeking ways to detect and treat Alzheimer’s before it causes irreversible brain damage.
Research indicates that the system for computing golfers’ handicaps favors strong, steady players. The professor will present his findings on Friday, September 15. 10:30 a.m., at the Charles F. Knight Center on Washington University’s campus. The lecture is sponsored by the Boeing Center for Technology, Information and Manufacturing at the Olin School of Business.
Red areas of the circled leg in the right image show increased blood flow due to angiogenic cells.To speed healing at sites of injury – such as heart muscle after a heart attack or brain tissue after a stroke – doctors would like to be able to hasten the formation of new blood vessels. One promising approach is to “mobilize” patients’ blood vessel-forming cells, called angiogenic cells, so these cells can reach the injured area. Recently, researchers at the School of Medicine demonstrated that a drug called AMD3100 can mobilize angiogenic cells from bone marrow of human patients in a matter of hours.